Skip to main content
. 2021 Sep 30;15:1297. doi: 10.3332/ecancer.2021.1297

Table 2. Comparison of different BT alternatives in LC treatment.

Characteristics BT type
LDRIB PDR HDRIB
Dose activity (Gy/h) 0.4–2 2–12 >12
Indications Tumours T1–T2.
Positive surgical margins
Post-surgical relapse.
Tumours T1–T3.
Positive surgical margins
Post-surgical relapse.
Tumours T1–T2, T4
(low-volume) Positive surgical margins
Post-surgical relapse.
Contraindications Bone infiltration Bone infiltration Bone infiltration
Local control (%) in 5 years 94%–96.6% 95% >95%